CANDIDA SP - ANVISA Registration 81816720046
Access comprehensive regulatory information for CANDIDA SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81816720046 and manufactured by VIRCELL S.L.. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, GENOBIO PHARMACEUTICAL CO., LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
81816720046
25351462004202323
31167508000102
Company Information
Dates and Status
Aug 14, 2023
VIGENTE
09/18/2025 19:00:01
CANDIDA SP
Candida albicans REAL-TIME PCR Detection Kit
DNA-TECHNOLOGY, RESEARCH & PRODUCTION
82149920111
Apr 07, 2025
CANDIDA SP
SERION ELISA classic Candida albicans IgG
INSTITUT VIRION\SERION GMBH
81905510082
Jul 10, 2023
CANDIDA SP
SERION ELISA classic Candida albicans IgM
INSTITUT VIRION\SERION GMBH
81905510084
Jul 10, 2023
CANDIDA SP
MM YEAST BLOOD
ALIFAX S.R.L.
81816720038
Jul 03, 2023
CANDIDA SP
Vaginal Yeast Test
SAVYON DIAGNOSTICS LTD
80464810781
Dec 02, 2021

